JP2002525077A - Ｔ型カルシウムチャンネル - Google Patents

Ｔ型カルシウムチャンネル

Info

Publication number
JP2002525077A
JP2002525077A JP2000570372A JP2000570372A JP2002525077A JP 2002525077 A JP2002525077 A JP 2002525077A JP 2000570372 A JP2000570372 A JP 2000570372A JP 2000570372 A JP2000570372 A JP 2000570372A JP 2002525077 A JP2002525077 A JP 2002525077A
Authority
JP
Japan
Prior art keywords
type calcium
calcium channel
pancreatic
cell
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000570372A
Other languages
English (en)
Japanese (ja)
Inventor
リー，ミング
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
South Alabama Medical Science Foundation
Original Assignee
South Alabama Medical Science Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by South Alabama Medical Science Foundation filed Critical South Alabama Medical Science Foundation
Publication of JP2002525077A publication Critical patent/JP2002525077A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
JP2000570372A 1998-08-26 1999-08-26 Ｔ型カルシウムチャンネル Pending JP2002525077A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US9800498P 1998-08-26 1998-08-26
US60/098,004 1998-08-26
US11739999P 1999-01-27 1999-01-27
US60/117,399 1999-01-27
PCT/US1999/019675 WO2000015845A1 (fr) 1998-08-26 1999-08-26 Canal calcique de type t

Publications (1)

Publication Number Publication Date
JP2002525077A true JP2002525077A (ja) 2002-08-13

Family

ID=26793874

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000570372A Pending JP2002525077A (ja) 1998-08-26 1999-08-26 Ｔ型カルシウムチャンネル

Country Status (5)

Country Link
EP (1) EP1108068A4 (fr)
JP (1) JP2002525077A (fr)
AU (1) AU6021799A (fr)
CA (1) CA2340586A1 (fr)
WO (1) WO2000015845A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008511297A (ja) * 2004-09-02 2008-04-17 ベーリンガー・インゲルハイム・インターナショナル・ゲーエムベーハー ＩＣＡ５１２はβ−細胞におけるインスリン分泌および遺伝子発現に関与する

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001062740A1 (fr) * 2000-02-25 2001-08-30 South Alabama Medical Science Foundation Analogues de mibefradil et leur utilisation
WO2001062741A1 (fr) 2000-02-25 2001-08-30 South Alabama Medical Science Foundation Derives de tetrahydronaphtalene et leur utilisation
US7166603B2 (en) 2003-07-23 2007-01-23 Bristol-Myers Squibb Co. Dihydropyrimidone inhibitors of calcium channel function
US7157461B2 (en) 2003-07-23 2007-01-02 Bristol-Myers Squibb Co. Substituted dihydropyrimidine inhibitors of calcium channel function
US7504431B2 (en) 2004-04-16 2009-03-17 Bristol-Myers Squibb Company Sulfonyl amide inhibitors of calcium channel function
CN101970427A (zh) 2008-02-29 2011-02-09 Vm生物医药公司 治疗疼痛症状及其它失调的方法
SG10201501496TA (en) * 2010-03-01 2015-04-29 Tau Therapeutics Llc Cancer diagnosis and imaging

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2061416T3 (es) * 1990-10-12 1997-03-01 Max Planck Gesellschaft Ribozimas modificadas.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008511297A (ja) * 2004-09-02 2008-04-17 ベーリンガー・インゲルハイム・インターナショナル・ゲーエムベーハー ＩＣＡ５１２はβ−細胞におけるインスリン分泌および遺伝子発現に関与する

Also Published As

Publication number Publication date
AU6021799A (en) 2000-04-03
EP1108068A4 (fr) 2002-12-04
WO2000015845A9 (fr) 2001-12-13
WO2000015845A1 (fr) 2000-03-23
EP1108068A1 (fr) 2001-06-20
CA2340586A1 (fr) 2000-03-23

Similar Documents

Publication Publication Date Title
JP4333862B2 (ja) 後根神経節におけるヒトナトリウムチャンネルの調節
US8663936B2 (en) Sodium channel protein type III α-subunit splice variant
JP2000060578A (ja) 新規ｇ―タンパク質結合レセプタ―（ｈｆｇａｎ７２ｘ）
JP2001525161A (ja) 低電位で活性化されるカルシウムチャネル組成物と方法
JP2010046088A (ja) 新規なぺプチド類
US7468422B2 (en) Mechanosensitive mammalian potassium channel activatable by polyunsaturated fatty acids
US20030125269A1 (en) T-type calcium channel
EP1007638B1 (fr) Canaux potassium de kcnq et methodes permettant de les moduler
JP2000106888A (ja) 新規ｇ―タンパク質結合レセプタ―（ｈｆｇａｎ７２ｙ）
JP2002508930A (ja) 脳又は心臓の環状ヌクレオチドによってゲーティングされるイオンチャンネル化合物及びその使用
US20070111943A1 (en) Tetrodotoxin-resistant sodium channel alpha subunit
IL114200A (en) Dna encoding high-affinity melatonin receptors
JP2002525077A (ja) Ｔ型カルシウムチャンネル
JP2000083669A (ja) Ｃｘｃｒ４ケモカイン受容体のヒトスプライス変異体ｃｘｃｒ４ｂ
JP2003534801A (ja) ヒトｋｃｎｑ５カリウムチャンネル、並びにその方法および組成物
JPH1175870A (ja) 新規なヒトｇ−タンパク質結合レセプター（ｈｃｅｐｔ０９）
JP2003530833A (ja) 有機化合物
JP2000515018A (ja) メラトニン１ａレセプター遺伝子調節領域およびその使用
JP4512273B2 (ja) 新規なぺプチド類
JP2003522522A (ja) 新規ヒトカルシウム感受性カリウムチャンネルサブユニット
EP1613769B1 (fr) Gene induit par l'insuline utilise comme cible therapeutique dans le diabete
JP2004508826A (ja) ヒトおよびラットｐｇｃ−３、ｐｐａｒ−ガンマ共活性化および該分子のスプライスバリアント
US20040175691A1 (en) Use of the KCNQ2 and KCNQ3 genes for the discovery of agents useful in the treatment of neurological disorders
US20040087530A1 (en) Methods and compositions for modulating leptin activity
JP2002509860A (ja) 後根神経節におけるナトリウムチャンネルの調節